Our Speakers



Our Speakers

Thomas Jahn
Thomas Jahn

Lab Head and Project Lead, Neuroscience Discovery, AbbVie, Germany

Peter St.George-Hyslop
Peter St.George-Hyslop

Director, Neurodegenerative Research, University of Toronto, Canada

Emilio Merlo-Pich
Emilio Merlo-Pich

Vice President, Takeda, UK

Richard Wade-Martins
Richard Wade-Martins

Professor, Molecular Neuroscience, Oxford University, UK

Nael Nadifkasri
Nael Nadifkasri

Group Leader, Molecular Neurophysiology, Radbound University, Netherlands

Fiona Elwood
Fiona Elwood

Head, Neurodegeneration, Novartis, USA

York Winter
York Winter

Professor, Cognitive Neurobiology, Charite University, Germany

James Ellis
James Ellis

Research Integrity Advisor, The Hospital for Sick Children, USA

Jones Isaac
Jones Isaac

Senior Director, Neuroscience External Innovation, Johnson & Johnson London Innovation Centre, UK

Michael Coleman
Michael Coleman

Professor, Neuroscience, University of Cambridge, USA

Jonathan Van Eyll
Jonathan Van Eyll

Senior Principal Scientist, Bioinformatics, UCB, Belgium

Dirk Schubert
Dirk Schubert

Assistant Professor Cellular Neurophysiology Radboud University Nijmegen Medical Centre, Netherlands

Shailendra Singh (Shelly)
Shailendra Singh (Shelly)

Chief Operating Officer

MarketsandMarkets

Georg Terstappen
Georg Terstappen

Head, Platform Technologies & Science China and PTS Neurosciences TA Portfolio Leader, GSK, China

Marianna Semprini
Marianna Semprini

Post Doc, Italian Institute of Technology

Emer Leahy
Emer Leahy

CEO

Psychogenics

Sandrine Willaime-Morawek
Sandrine Willaime-Morawek

Associate Professor, Stem Cells and Neurobiology

University of Southampton

Jean-Pierre Mothet
Jean-Pierre Mothet

Director, Research CNRS

Aix-Marseille University

Roland Heym
Roland Heym

Lab Head, Molecular & Imaging Biomarker

AbbVie